Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$155,925
+$36,355 QoQ
Shares Held
130
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,939
of 2,003 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monetary Solutions, Ltd holds $3,711,271 across 15 Drug Manufacturers - General names. LLY ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,687 | $1,934,356 | |
| 2 | JNJ |
Johnson & Johnson
|
4,268 | $1,083,943 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,049 | $263,296 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
130 | $155,925 | |
| 5 | AMGN |
Amgen Inc
|
359 | $130,001 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,400 | $80,668 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
416 | $52,557 | |
| 8 | NVS |
Novartis AG
|
16 | $2,507 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,925 | 130 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $119,570 | 130 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $139,708 | 130 | Shares | Sole | 2026-02-23 | |
| No filing history on record for this holder in this stock. | ||||||